mn-166
Showing 1 - 5 of 5
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)
Active, not recruiting
- Glioblastoma
- +3 more
- MN-166
- Temozolomide
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 16, 2022
Amyotrophic Lateral Sclerosis Trial in Charlotte (Placebo (for MN-166), MN-166, riluzole)
Completed
- Amyotrophic Lateral Sclerosis
- Placebo (for MN-166)
- +2 more
-
Charlotte, North CarolinaCarolinas Healthcare System, Dept. of Neurology
Oct 7, 2021
Amyotrophic Lateral Sclerosis Trial in Canada, United States (MN-166, )
Recruiting
- Amyotrophic Lateral Sclerosis
- MN-166
- placebo
-
Orange, California
- +23 more
Jan 24, 2023
Healthy Volunteers Trial in Garden Grove (MN-166)
Completed
- Healthy Volunteers
- MN-166
-
Garden Grove, CaliforniaCollaborative Neuroscience Network
Jul 13, 2020
Healthy Volunteers Trial in Cypress (MN-166)
Completed
- Healthy Volunteers
- MN-166
-
Cypress, CaliforniaWCCT Global, Inc.
May 29, 2019